Abstract Purpose of Review Cancer and cardiovascular disease are the leading causes of
mortality in the USA. In this review, we highlight these shared disease pathways and provide …

Ibrutinib is the first-in-class Bruton tyrosine kinase (BTK) inhibitor that has revolutionized the
treatment of B cell malignancies. Unfortunately, increased incidences of cardiotoxicity have …

To date, five cancer treatment modalities have been defined. The three traditional modalities
of cancer treatment are surgery, radiotherapy, and conventional chemotherapy, and the two …

Cancer treatment has been associated with accelerated aging that can lead to early-onset
health complications typically experienced by older populations. In particular, cancer …

Immune checkpoint inhibitors have demonstrated significant clinical benefit in many
cancers. The clinical benefit afforded by these treatments can be accompanied by a unique …

Abstract Purpose of Review As cancer screening and treatment continue to improve, the
number of cancer survivors is growing rapidly. Cardiovascular disease is the leading cause …

Cardiovascular complications have been frequently reported in cancer patients and
survivors, mainly because of various cardiotoxic cancer treatments. Despite the known …

Breast cancer and cardiovascular diseases (CVD) represent significant global health
challenges, with CVD being the leading cause of mortality and breast cancer, showing a …

The neuropeptide hormone oxytocin, which is released from the posterior pituitary gland, is
involved in a number of physiological processes. Understanding of its effects is gradually …

Cardio-oncology is a clinical/scientific discipline which aims to prevent and/or treat
cardiovascular diseases in cancer patients. Although a large number of cancer treatments …